Integrative machine learning of hypoxia and centrosome-related gene signatures enables prognostic stratification and therapeutic insights in lung adenocarcinoma

Key Points

• Hypoxia and centrosome-related gene signatures provide a robust framework for risk stratification in lung adenocarcinoma.
• The model identifies actionable targets for targeted therapy, enhancing precision in oncology treatments.
• This approach integrates complex gene interactions using machine learning to deepen understanding of cancer mechanisms.
• Potential implications include better personalized strategies for treating lung adenocarcinoma based on specific gene profiles.